STORM Therapeutics pioneering founders have led the discovery of the role that RNA modifying enzymes play in a variety of diseases, including cancer and viral infection.
Leveraging these biological insights, the team at STORM Therapeutics have progressed the first drug capable of targeting these enzymes therapeutically into the clinic, potentially opening an entirely new class of therapeutics.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. Without these cookies, some parts of our site or the service being requested will be impossible to provide.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.